These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11149746)

  • 21. Isolated testicular relapse after bone marrow transplant with total body irradiation and testicular boost in acute lymphoblastic leukemia.
    Li CK; Shing MM; Chik KW; Kwan WH; Lai DH; Leung TF; Yuen PM
    Bone Marrow Transplant; 1998 Aug; 22(4):397-9. PubMed ID: 9722077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
    Mrsić M; Nemet D; Labar B; Bogdanić V; Radman I; Zupancić-Salek S; Kovacević-Metelko J; Aurer I; Maravić N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1268-70. PubMed ID: 8442109
    [No Abstract]   [Full Text] [Related]  

  • 23. Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia.
    Kang HJ; Shin HY; Choi HS; Han KS; Ahn HS
    Bone Marrow Transplant; 2004 Mar; 33(5):471-6. PubMed ID: 14716339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide.
    Konuma T; Kato S; Oiwa-Monna M; Tojo A; Takahashi S
    Leuk Lymphoma; 2015 Apr; 56(4):1148-50. PubMed ID: 25093379
    [No Abstract]   [Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.
    Hale GA; Bowman LC; Woodard JP; Cunningham JM; Benaim E; Horwitz EM; Heslop HE; Krance RA; Leung W; Shearer PD; Handgretinger R
    Bone Marrow Transplant; 2003 Jun; 31(11):981-6. PubMed ID: 12774048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VP16 and TBI as conditioning regimen for allogeneic BMT in patients with high risk and relapsed ALL and NHL.
    Schwerdtfeger R; Schmid H; Baurmann H; Kleiner S; Zeiler T; Henze G; Siegert W
    Bone Marrow Transplant; 1991; 7 Suppl 2():131. PubMed ID: 1878676
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemolytic uremic syndrome after autologous BMT without TBI.
    Raybon KB; Snyder MJ; Halvorson RD
    Bone Marrow Transplant; 1996 May; 17(5):897-8. PubMed ID: 8733719
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.
    Choi SJ; Lee JH; Lee JH; Kim S; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Jang S; Park CJ; Chi HS; Lee KH
    Bone Marrow Transplant; 2005 Jul; 36(2):163-9. PubMed ID: 15937507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.
    Talano JM; Casper JT; Camitta BM; Keever-Taylor CA; Murray KJ; Eapen M; Pierce KL; Margolis DA
    Bone Marrow Transplant; 2006 Jan; 37(2):135-41. PubMed ID: 16273115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late relapse after autologous BMT.
    Salutari P; Micciulli G; Chiusolo P; Tommasi M; Di Mario A; Sica S; Leone G
    Leukemia; 1996 May; 10(5):922-3. PubMed ID: 8656692
    [No Abstract]   [Full Text] [Related]  

  • 32. A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation.
    Yoshimi A; Nannya Y; Sakata-Yanagimoto M; Oshima K; Takahashi T; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2008 Aug; 83(8):635-9. PubMed ID: 18506704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
    Uehara T; Nakaseko C; Yokota A; Saito Y; Nishimura M
    Am J Hematol; 2002 Sep; 71(1):37-40. PubMed ID: 12221672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Outcome of autologous bone marrow transplantation in 73 patients with acute leukemia].
    Han M; Feng S; Li C
    Zhonghua Xue Ye Xue Za Zhi; 1998 Aug; 19(8):422-4. PubMed ID: 11189510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total body irradiation, cyclophosphamide, and etoposide with stem cell transplant as treatment for infants with acute lymphocytic leukemia.
    Pirich L; Haut P; Morgan E; Marymount M; Kletzel M
    Med Pediatr Oncol; 1999 Jan; 32(1):1-6. PubMed ID: 9917745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total body irradiation before allogeneic bone marrow transplantation: is more dose better?
    Bieri S; Helg C; Chapuis B; Miralbell R
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1071-7. PubMed ID: 11240249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.
    Horstmann MA; Hassenpflug WA; zur Stadt U; Escherich G; Janka G; Kabisch H
    Haematologica; 2005 Dec; 90(12):1701-3. PubMed ID: 16330449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults.
    Arai Y; Kondo T; Shigematsu A; Tanaka J; Ohashi K; Fukuda T; Kawakita T; Mori T; Hoshino T; Onizuka M; Ozawa Y; Yoshida S; Ueda Y; Mizuno I; Atsuta Y; Mizuta S;
    Br J Haematol; 2017 Jul; 178(1):106-111. PubMed ID: 28439877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.
    Mori T; Aisa Y; Yokoyama A; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Kato J; Watanabe R; Takayama N; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2007 Feb; 39(4):217-21. PubMed ID: 17220902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.
    Russo D; Malagola M; de Vivo A; Fiacchini M; Martinelli G; Piccaluga PP; Damiani D; Candoni A; Michielutti A; Castelli M; Testoni N; Ottaviani E; Rondoni M; Pricolo G; Mazza P; Zuffa E; Zaccaria A; Raspadori D; Bocchia M; Lauria F; Bonini A; Avanzini P; Gugliotta L; Visani G; Fanin R; Baccarani M
    Br J Haematol; 2005 Oct; 131(2):172-9. PubMed ID: 16197446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.